Atherosclerotic Cardiovascular Disease (ASCVD) Apolipoprotein B, B/A Ratio

Last Literature Review: October 2022 Last Update:
About This Topic

There is insufficient evidence to recommend or discourage the use of certain nontraditional markers in asymptomatic adults. Apolipoprotein B/A Ratio (0050028) biomarker testing may be considered for intermediate- to high-risk patient subgroups as identified from the initial screening.

Recommendation

A fasting Lipid Panel (0020421) with total cholesterol, triglycerides, LDL, and HDL should be used for screening.

C-Reactive Protein, High Sensitivity (0050182) and Lp-PLA2, Lipoprotein-Associated Phospholipase A2, Activity (PLAC) (3002266) may aid in CVD risk stratification in specific populations.